Multiple Skleroz ile FOXP3 geni promotor bölge mutasyonları arasındaki ilişki
Amaç: Bağışıklık sistemi bileşenlerinden biri olan düzenleyici T (Treg) hücreleri, özellikle multiple skleroz (MS) gibi otoimmün hastalıkların önlenmesinde oldukça etkilidir. Multiple skleroz (MS), santral sinir sisteminde immün hücre infiltrasyonu ve inflamasyonla karakterize kronik inflamatuar, otoimmün bir hastalıktır. Treg hücreleri otoimmünitenin kontrolünde önemli bir rol oynar. Treg’lerin gelişimi ve işlevi, transkripsiyon faktörü FOXP3’ün (Transkripsiyon Faktörü Forkhead Box P3) uygun ifadesine ve hareketine bağlıdır. Bu bağlamda çalışmamızın amacı, MS ve FOXP3 geni yaygın promotor bölge mutasyonlarından rs2232365 (-924 A/G) ve rs3761548 (-3279 A/C) arasındaki ilişkinin bir Türk popülasyonunda araştırılması olarak belirlenmiştir. Yöntem: Çalışma kapsamında 80 MS hastası ve 80 sağlıklı kontrol bireyinden alınan kan örnekleri kullanılmıştır. Foxp3 genotipleri PCR-RFLP yöntemi kullanılarak belirlenmiştir. Bulgular: Elde edilen sonuçlar istatistiksel olarak değerlendirildiğinde, MS ve FOXP3 rs3761548 polimorfizmi arasında anlamlı bir ilişki gözlenmiştir (p= 0.031). Bunun aksine araştırılan diğer polimorfizm, rs2232365, MS hastalarında hastalıkla ilişkili bulunmamıştır (p= 0.31). Sonuç: FOXP3 geni, bağışıklık hücrelerinin düzenlenmesinde en önemli genlerden biri olduğundan, MS hastalarında bu genin ekspresyonunun önemli olduğu sonucuna varılabilir. Bu SNP (Tek Nükleotit Polimorfizmi), genin promotor bölgesinde yer aldığından FOXP3 proteinin ekspresyon seviyesini etkileyebilir.
Association between Multiple Sclerosis and FOXP3 Gene promoter region mutations
Regulatory T-Cells (Treg Cells), as one of the immune system components, have been highly effective in theautoimmune diseases prevention, particularly multiple sclerosis (MS). MS is a chronic inflammatory and autoimmunedisease characterized by immune infiltration and inflammation in the central nervous system. Regulatory T (Treg) cellsplay an important role in the control of autoimmunity. Expression and action of the transcription factor FOXP3 controlsthe development and function of Treg cell. The aim of this study was to investigate the association between MS andFOXP3 gene promoter region polymorphisms rs2232365 (-924A/G) and rs3761548 (-3279A/C) in a Turkishpopulation. In this case-control study we investigated these polymorphisms in 80 MS patients and 80 healthy controlsusing PCR-RFLP methods.Results of our study showed that while there is significant correlation between MS and FOXP3 rs3761548polymorphism (p=0.031), FOXP3 rs2232365 polymorphism, has not been found to be associated with the disease(p=0.31). As FOXP3 gene is one of the most important genes in the regulation of the immune cells, it may beconcluded that the expression of this gene is important in MS patients. As this SNP is located in the promoter region ofthe gene, it may affect the expression level of FOXP3 protein.
___
- Hafler DA, Slavik JM, Anderson DE,
O’Connor KC, De Jager P, Baecher-Allan
C. Multiple sclerosis. Immunol Rev, 2005;
204:208-231.
- İdiman E. Multipl skleroz’un
immünopatogenezi. Türkiye Klinikleri J
Neur, 2004; 2:171-176.
- Weissert R. The immune pathogenesis of
Multiple sclerosis. Pharmacol, 2013;
8:857-866.
- Piccirillo AC, Shevach ME. Naturally
occuring CD4(+)CD25(+)
immunoregulatory T cells: central players
in the arena of peripheral tolerance. Semin
Immunol, 2004; 16(2):81-88.
- Işık N, Yıldız-Manukyan N, Aydın-
Cantürk İ, Candan F, Ünsal-Çakmak A,
Saruhan-Direskeneli G. Multipl skleroza
genetik yatkınlık: Foxp3 gen polimorfizmin rolü. Nöropsikiyatri Arşivi,
2014; 51:69-73.
- Singer BD, King LS, D’Alessio FR.
Regulatory T cells as immunotherapy.
Front Immunol, 2014; 5:46.
- Viglietta V, Baecher-Allan C, Weiner HI,
Hafler DA. Loss of functional supression
by CD4+CD25+ regulatory T cells from
patients with Multiple sclerosis. J Exp
Med, 2004; 199:971-979.
- Yadav SK, Mindur JE, Ito K, Dhib-Jalbut
S. Advances in the immunopathogenesis
of Multiple sclerosis. Curr Opin Neurol,
2015; 28:206-219.
- Aranami T, Yamamura T. Th17 cells and
autoimmune encephalomyelitis
(EAE/MS). Allergo Int, 2008; 57:115-
120.
- Dendrou CA, Fugger L, Friese MA.
Immunopathology of Multiple sclerosis.
Nat Rev Immunol, 2015; 15:545-558.
- Bos SD, Berge T, Cellus EG, Harbo HF.
From genetic associations to functional
studies in Multiple sclerosis. Eur J
Neurol, 2016; 23:847-853.
- Chang D, Gao F, Slavney A, Ma L,
Waldman YY, Sams AJ, et al. Accounting
for eXentricties: analysisof the X
chromosome in GWAS reveals X-linked
genes implicated in autoimmune diseases.
Plos One, 2014; 9:e113684.
- Hollenbach JA, Oksenberg JR. The
immunogenetics of Multiple sclerosis: A
comprehensive review. J Autoimmun,
2015; 64:13-25.
- Oda JMM, Hirata BKB, Guembarovski
RL, Watanabe MAE. Genetic
polymorphism in FOXP3 gene: imbalance
in regulatory T-cell role and development
of human diseases. J.Genet. 2013;
92:163–171.
- Katoh H, Zheng P, Liu Y. Foxp3: genetic
and epigenetic implications for
autoimmunity. J Autoimmun, 2013; 41:72-
78.
- Marques CR, Costa GN, da Silva TM,
Telxira TO, de Andrade EM, et al.
Genetic and epigenetic studies of Foxp3
in asthma and allergy. Asthma Res Pract,
2015; 1:10.
- Gajdosechova B, Javor J, Cierny D,
Michalik J, Durmanova V, Shawkatova I,
Parnicka Z, et al. Association of Foxp3
polymorphisms rs3761547 and rs3761548
with Multiple sclerosis in the Slovak
population. Act Nerv Super Rediviva,
2017; 59(1):9-15.
- Polman CH, Reingold SC, Edan G,
Filippi M, Hartung HP, Kappos L, Lublin
FD, Metz LM, McFarland HF, O’Connor
PW, Sandberg-Wollheim M, Thompson
AJ, Weinshenker BG, Wolinsky JS.
Diagnostic criteria for Multiple sclerosis:
2005 revisions to the “McDonald
Criteria”. Ann Neurol, 2005; 58:840-846.
- Ullrich A, Shine J, Chirgwin J, et al. Rat
insülin genes: construction of plasmids
containing the coding sequences. Science,
1977; 196(4296):1313-1319.
- International Multiple Sclerosis Genetic
Consortium (IMSGC), Beecham AH,
Patsopoulos NA, Xifara DK, Davis MF,
Kemppien A, et al. Analysis of immunerelated
loci identifies 48 new
susceptibility variants for Multiple
sclerosis. Nat Genet, 2013; 45:1353-1360.
- Graber J, McGraw C, Kimbrough D,
Dhib-Jalbut S. Overlapping and distinct
mechanisms of action of Multiple
sclerosis therapies. Clin Neurol
Neurosurg, 2010; 112:583-591.
- Men M, Kutlu C, İlhan-Algın D, Gülbaş
Z. The Cd4(+)Cd25(+) regulatory T cell
profile and Foxp3 expression and clinic
associations of in various stage and types
of Multiple sclerosis. Osmangazi Journal
of Medicine, 2018; 40(1):7-13.
- Coffer PJ, Burgering BMT. Forkhead-box
transcription factors and their role in the
immune system. Nat Rev, 2004; 4:889-
899.
- Gagliani N, Jofra T, Valle A, Stabilini A,
Morsiani C, Gregori S, Deng S, Rothstein
DM, Arkinson M, Kamanaka M, Flavell
RA, Roncarolo MG, Battaglia M.
Transplant tolerance to pancreatic islets is
initiated in the graft and sustained in the
spleen. Am J Transplant, 2013;
13(8):1963-75.
- Koyama M, Kuns RD, Olver SD,
Lineburg KE, Lor M, Teal BE, Raffelt
NC, Levegue L, Chan CJ, et al.
Promoting regulation via the inhibition of
DNAM-1 after transplantation. Blood,
2013; 121(17):35111-20.
- Huan J, Culbertson N, Spencer L,
Bartholomew R, Burrows GG, Chou YK,
Bourdette D, Ziegler SF, Offner H,
Vandenbark AA. Decreased Foxp3 levels
in Multiple sclerosis patients. Journal of
Neuroscience Research, 2005; 81:45-52.
- Jafarzadeh A, Jamali M, Mahdavi R,
Ebrahimi HA, Hajghani H,
Khosravimashizi A, Nemati M, Najafipour H, Sheikhi A, Mohammadi
MM, Daneshvar H. Circulating levels of
interleukin-35 in patients with Multiple
sclerosis: evaluation of the influences of
Foxp3 gene polymorphsism and treatment
program. J Mol Neurosci, 2015; 55:891-
897.
- Efekharian MM, Sayad A, Omrani MD,
Ghannad MS, Noroozi R, Mazdeh M, et
al. Single nucleotide polymorphisms in
the Foxp3 gene are associated with
incrased risk of relapsing-remitting
multiple sclerosis. Hum Antibodies, 2016;
doi: 10.3233/HAB-160299.
- Gholami M, Darvish H, Ahmadi H,
Rahimi-Aliabadi S, Emamalizadeh B,
Eslami Amirabadi MR, et al. Functional
genetic variants of Foxp3 and risk of
multiple sclerosis. Iran Red Crescent Med
J, 2016; e34597.